Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Reliq Health Technologies Inc. (RQHTF) had Revenue of $6.76M for the most recently reported fiscal year, ending 2022-06-30.

Quarterly Annual

Figures for fiscal year ending 2022-06-30

Income Statement Financials
Revenue	$6.76M
Net Income	$-6.46M
Cost of Goods Sold	$2.57M
Gross Profit	$4.19M
Operating Expenses	$12.76M
Operating Income	$-6.00M
Non-Operating Income/Expense	$-0.46M
Pre-Tax Income	$-6.46M
Normalized Pre-Tax Income	$-6.46M
Income after Taxes	$-6.46M
Income from Continuous Operations	$-6.46M
Consolidated Net Income/Loss	$-6.46M
Normalized Income after Taxes	$-6.46M
EBIT	$-6.00M
EBITDA	$-5.91M
Weighted-Average Shares Outstanding (Basic)	183.09M
Weighted-Average Shares Outstanding (Diluted)	183.09M
Earnings per Share (EPS) (Basic)	$-0.03
Earnings per Share (EPS) (Diluted)	$-0.03
Balance Sheet Financials
Current Assets	$5.51M
Property, Plant, and Equipment	--
Long-Term Assets	$2.61M
Total Assets	$8.11M
Current Liabilities	$2.93M
Long-Term Debt	$0.03M
Long-Term Liabilities	$0.15M
Total Liabilities	$3.08M
Common Equity	$5.03M
Tangible Shareholders Equity	$5.03M
Shareholders Equity	$5.03M
Common Shares Outstanding	188.58M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.34M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$6.27M
Beginning Cash	$0.18M
End Cash	$0.10M
Increase/Decrease in Cash	$-0.07M
Stock-Based Compensation	$4.35M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	0.01
Gross Margin	61.99%
Operating Margin	-88.79%
EBIT Margin	-88.79%
EBITDA Margin	-87.44%
Pre-Tax Profit Margin	-95.55%
Profit Margin	-95.55%
Free Cash Flow	$-6.34M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.83
Inventory Turnover	11.93
Receiveable Turnover	1.34
Days Sales in Receivables	271.48
Return on Equity	-128.26%
Return on Tangible Equity	-128.26%
Return on Assets	-79.58%
Return on Investments	-127.46%
Book Value Per Share	$0.03
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.03

Data from Zacks Investment Research, Inc.